Average Co-Inventor Count = 3.2

ph-index = 3

Forward Citations = 38(Granted Patents)

Location History:

Rennes, FR (2003)
Vourles, FR (2003 - 2008)
Lyon Cedex, FR (2014)
Lyons Cedex, FR (2014)
Lyons, FR (2015 - 2018)

Company Filing History:

8 out of 1,743

Institut National De La Sante Et De La Recherche Medicale

patents

3 out of 208

Universite Claude Bernard – Lyon1

patents

2 out of 4

Ens-ecole Normale Superieure De Lyon

patents

4. 2 out of 5,069

Centre National De La Recherche Scientifique

8. 2 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 2003-2018

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10071108 - Methods and pharmaceutical compositions for the treatment of hepatitis b virus infection (2018-09-11),

2. 9895380 - Methods and pharmaceutical compositions for the treatment of hepatitis B virus infection (2018-02-20),

3. 9695446 - Direct protein delivery with engineered microvesicles (2017-07-04),

4. 9168236 - Methods and pharmaceutical compositions for inhibiting influenza viruses replication (2015-10-27),

5. 8716020 - Reprogrammation of eukaryotic cells with engineered microvesicles (2014-05-06),

6. 8697439 - Direct protein delivery with engineered microvesicles (2014-04-15),

7. 7368287 - Use of L-α-lysophosphatidylcholine to obtain the differentiation of monocytes into mature dendritic cells in vitro (2008-05-06),

8. 7259012 - Use of oxidized lipoproteins for differentiation of precursor cells into mature dendritic cells (2007-08-21),

9. 6548295 - Complex of lipo-viro-particles, method of preparation and applications (2003-04-15),

10. 6506555 - Use of HIV protease inhibiting compounds (2003-01-14),

Title: Vincent Lotteau: Innovator in Hepatitis B Treatment

Introduction

Vincent Lotteau is a prominent inventor based in Lyons, France. He has made significant contributions to the field of medicine, particularly in the treatment of viral infections. With a total of 10 patents to his name, Lotteau's work has the potential to impact many lives.

Latest Patents

One of Lotteau's latest patents focuses on methods and pharmaceutical compositions for the treatment of hepatitis B virus infection. This invention specifically relates to farnesoid X receptor (FXR) agonists, which are utilized in methods aimed at treating hepatitis B virus infection in subjects who require such intervention. His innovative approach offers new avenues for addressing this challenging health issue.

Career Highlights

Throughout his career, Vincent Lotteau has been associated with esteemed institutions, including the Institut National De La Santé Et De La Recherche Médicale. His work in these organizations has allowed him to advance his research and develop groundbreaking treatments.

Collaborations

Lotteau has collaborated with notable colleagues such as Patrice Andre and Philippe Mangeot. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in the medical field.

Conclusion

Vincent Lotteau's contributions to the treatment of hepatitis B virus infection exemplify his dedication to medical innovation. His patents and collaborations reflect a commitment to improving health outcomes for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.